20 Stocks Moving in Tuesday's Pre-Market Session_老虎社区_美港股上老虎

20 Stocks Moving in Tuesday's Pre-Market Session

Benzinga2022-01-25

GainersAptorum Group Limited shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

InvisibleP
·2022-01-25
Good?
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1170678499?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-01-25 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170678499","market":"us","top_or_hot":-1,"title":"20 Stocks Moving in Tuesday's Pre-Market Session","media":"Benzinga","content":"<div>\n<p>GainersAptorum Group Limited shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/25203816/20-stocks-moving-in-tuesdays-pre-market-session\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>20 Stocks Moving in Tuesday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n20 Stocks Moving in Tuesday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-25 20:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/25203816/20-stocks-moving-in-tuesdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GainersAptorum Group Limited shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/25203816/20-stocks-moving-in-tuesdays-pre-market-session\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"https://www.benzinga.com/news/22/01/25203816/20-stocks-moving-in-tuesdays-pre-market-session","article_id":"1170678499","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170678499","pubTimestamp":1643112515,"columns":[],"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"GainersAptorum Group Limited shares rose 94.4% to $3.15 in pre-market trading after gaining around 1","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen","IBM":"IBM"},"translate_title":"周二盘前20只股票走势","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBM":0.9,"OCGN":0.9},"content_text":"GainersAptorum Group Limited shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a repurposed small molecule compound for Neuroblastoma.Esports Entertainment Group, Inc. rose 16.1% to $3.17 in pre-market trading. Esports Entertainment, on Monday, received an order approving a transactional waiver from the Director of the New Jersey Division of Gaming Enforcement, permitting the company to begin accepting bets in the state.BT Brands, Inc. rose 8.1% to $3.35 in pre-market trading after climbing around 28% on Monday.Kintara Therapeutics, Inc. rose 8% to $0.3995 in pre-market trading after declining more than 6% on Monday.Innate Pharma S.A. shares rose 8% to $4.01 in pre-market trading following a 10% drop on Monday.Logitech International S.A. rose 7.5% to $80.01 in pre-market trading as the company posted upbeat quarterly results and raised fiscal 2022 forecast.WISeKey International Holding AG shares rose 7.2% to $3.69 in pre-market trading.Telefonaktiebolaget LM Ericsson rose 7% to $11.66 in pre-market trading after reporting upbeat core earnings for its fourth quarter.Zosano Pharma Corporation rose 6.4% to $0.5080 in pre-market trading. Zosano Pharma, on January 18, resubmitted its M207 (Zolmitriptan Transdermal Microneedle System) 505(B)(2) NDA to the FDA.International Business Machines Corporation rose 2.8% to $132.40 in pre-market trading after the company reported better-than-expected fourth-quarter EPS and sales results.LosersVaxxinity, Inc. shares fell 13.4% to $7.44 in pre-market trading after gaining more than 5% on Monday. Vaxxinity recently said the first Parkinson's disease patient was dosed in Part B of a Phase 1 clinical trial of UB-312.Pulmatrix, Inc. shares fell 10.5% to $0.35 in pre-market trading. Pulmatrix, last month, announced a $6.75 million registered direct offering.Blue Star Foods Corp. shares fell 10.5% to $3.55 in pre-market trading after gaining around 5% on Monday.Brickell Biotech, Inc. shares fell 8.5% to $0.2116 in pre-market trading. HC Wainwright & Co recently initiated coverage on the stock with a Buy rating and $2 price target.NeuroBo Pharmaceuticals, Inc. fell 8.5% to $1.07 in pre-market trading after gaining around 5% on Monday.TCR2 Therapeutics Inc. fell 7.3% to $3.30 in pre-market trading. Goldman Sachs, last week, downgraded TCR2 Therapeutics from Buy to Neutral and lowered the price target from $28 to $5.Pintec Technology Holdings Limited fell 6.4% to $0.6161 in pre-market trading after dipping more than 52% on Monday.Reviva Pharmaceuticals Holdings, Inc. shares fell 6.4% to $1.76 in pre-market trading. HC Wainwright & Co, on Monday, initiated coverage on Reviva Pharmaceuticals with a Buy rating and announced a price target of $10.Ocugen, Inc. fell 5.4% to $3.14 in pre-market trading. Ocugen, on Monday, named Nirdosh Jagota, Ph.D., as Senior Vice President (SVP), Regulatory Affairs, compliance and safety.Society Pass Incorporated fell 5.3% to $5.00 in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":639916758,"gmtCreate":1643118958438,"gmtModify":1643118958543,"author":{"id":"3585470994468822","authorId":"3585470994468822","name":"InvisibleP","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3585470994468822","authorIdStr":"3585470994468822"},"htmlText":"Good?&nbsp;","listText":"Good?&nbsp;","text":"Good?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639916758","repostId":1170678499,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}